Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
Display Omitted
Autor*in: |
Morganti, Stefania [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019 |
---|
Schlagwörter: |
---|
Umfang: |
12 |
---|
Übergeordnetes Werk: |
Enthalten in: miR-214 in stroma cells and tumor progression - Dettori, D. ELSEVIER, 2016, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:133 ; year:2019 ; pages:171-182 ; extent:12 |
Links: |
---|
DOI / URN: |
10.1016/j.critrevonc.2018.11.008 |
---|
Katalog-ID: |
ELV045484325 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV045484325 | ||
003 | DE-627 | ||
005 | 20230624115101.0 | ||
007 | cr uuu---uuuuu | ||
008 | 190205s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.critrevonc.2018.11.008 |2 doi | |
028 | 5 | 2 | |a GBV00000000000492.pica |
035 | |a (DE-627)ELV045484325 | ||
035 | |a (ELSEVIER)S1040-8428(18)30422-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.52 |2 bkl | ||
100 | 1 | |a Morganti, Stefania |e verfasserin |4 aut | |
245 | 1 | 0 | |a Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
264 | 1 | |c 2019 | |
300 | |a 12 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Display Omitted | ||
650 | 7 | |a Tumor mutational burden |2 Elsevier | |
650 | 7 | |a Precision medicine |2 Elsevier | |
650 | 7 | |a Driver mutations |2 Elsevier | |
650 | 7 | |a Predictive biomarkers |2 Elsevier | |
650 | 7 | |a Tumor heterogeneity |2 Elsevier | |
650 | 7 | |a Liquid biopsy |2 Elsevier | |
650 | 7 | |a Next generation sequencing |2 Elsevier | |
700 | 1 | |a Tarantino, Paolo |4 oth | |
700 | 1 | |a Ferraro, Emanuela |4 oth | |
700 | 1 | |a D’Amico, Paolo |4 oth | |
700 | 1 | |a Viale, Giulia |4 oth | |
700 | 1 | |a Trapani, Dario |4 oth | |
700 | 1 | |a Duso, Bruno Achutti |4 oth | |
700 | 1 | |a Curigliano, Giuseppe |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Dettori, D. ELSEVIER |t miR-214 in stroma cells and tumor progression |d 2016 |g Amsterdam [u.a.] |w (DE-627)ELV019637179 |
773 | 1 | 8 | |g volume:133 |g year:2019 |g pages:171-182 |g extent:12 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.critrevonc.2018.11.008 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2016 | ||
912 | |a GBV_ILN_2048 | ||
936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
951 | |a AR | ||
952 | |d 133 |j 2019 |h 171-182 |g 12 |
author_variant |
s m sm |
---|---|
matchkey_str |
morgantistefaniatarantinopaoloferraroema:2019----:opeiyfeoeeunignrprigeteeaineuniggtcnlgeadmlmna |
hierarchy_sort_str |
2019 |
bklnumber |
44.52 |
publishDate |
2019 |
allfields |
10.1016/j.critrevonc.2018.11.008 doi GBV00000000000492.pica (DE-627)ELV045484325 (ELSEVIER)S1040-8428(18)30422-0 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.52 bkl Morganti, Stefania verfasserin aut Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Elsevier Tarantino, Paolo oth Ferraro, Emanuela oth D’Amico, Paolo oth Viale, Giulia oth Trapani, Dario oth Duso, Bruno Achutti oth Curigliano, Giuseppe oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:133 year:2019 pages:171-182 extent:12 https://doi.org/10.1016/j.critrevonc.2018.11.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 133 2019 171-182 12 |
spelling |
10.1016/j.critrevonc.2018.11.008 doi GBV00000000000492.pica (DE-627)ELV045484325 (ELSEVIER)S1040-8428(18)30422-0 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.52 bkl Morganti, Stefania verfasserin aut Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Elsevier Tarantino, Paolo oth Ferraro, Emanuela oth D’Amico, Paolo oth Viale, Giulia oth Trapani, Dario oth Duso, Bruno Achutti oth Curigliano, Giuseppe oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:133 year:2019 pages:171-182 extent:12 https://doi.org/10.1016/j.critrevonc.2018.11.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 133 2019 171-182 12 |
allfields_unstemmed |
10.1016/j.critrevonc.2018.11.008 doi GBV00000000000492.pica (DE-627)ELV045484325 (ELSEVIER)S1040-8428(18)30422-0 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.52 bkl Morganti, Stefania verfasserin aut Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Elsevier Tarantino, Paolo oth Ferraro, Emanuela oth D’Amico, Paolo oth Viale, Giulia oth Trapani, Dario oth Duso, Bruno Achutti oth Curigliano, Giuseppe oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:133 year:2019 pages:171-182 extent:12 https://doi.org/10.1016/j.critrevonc.2018.11.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 133 2019 171-182 12 |
allfieldsGer |
10.1016/j.critrevonc.2018.11.008 doi GBV00000000000492.pica (DE-627)ELV045484325 (ELSEVIER)S1040-8428(18)30422-0 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.52 bkl Morganti, Stefania verfasserin aut Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Elsevier Tarantino, Paolo oth Ferraro, Emanuela oth D’Amico, Paolo oth Viale, Giulia oth Trapani, Dario oth Duso, Bruno Achutti oth Curigliano, Giuseppe oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:133 year:2019 pages:171-182 extent:12 https://doi.org/10.1016/j.critrevonc.2018.11.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 133 2019 171-182 12 |
allfieldsSound |
10.1016/j.critrevonc.2018.11.008 doi GBV00000000000492.pica (DE-627)ELV045484325 (ELSEVIER)S1040-8428(18)30422-0 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.52 bkl Morganti, Stefania verfasserin aut Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Elsevier Tarantino, Paolo oth Ferraro, Emanuela oth D’Amico, Paolo oth Viale, Giulia oth Trapani, Dario oth Duso, Bruno Achutti oth Curigliano, Giuseppe oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:133 year:2019 pages:171-182 extent:12 https://doi.org/10.1016/j.critrevonc.2018.11.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 133 2019 171-182 12 |
language |
English |
source |
Enthalten in miR-214 in stroma cells and tumor progression Amsterdam [u.a.] volume:133 year:2019 pages:171-182 extent:12 |
sourceStr |
Enthalten in miR-214 in stroma cells and tumor progression Amsterdam [u.a.] volume:133 year:2019 pages:171-182 extent:12 |
format_phy_str_mv |
Article |
bklname |
Therapie |
institution |
findex.gbv.de |
topic_facet |
Tumor mutational burden Precision medicine Driver mutations Predictive biomarkers Tumor heterogeneity Liquid biopsy Next generation sequencing |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
miR-214 in stroma cells and tumor progression |
authorswithroles_txt_mv |
Morganti, Stefania @@aut@@ Tarantino, Paolo @@oth@@ Ferraro, Emanuela @@oth@@ D’Amico, Paolo @@oth@@ Viale, Giulia @@oth@@ Trapani, Dario @@oth@@ Duso, Bruno Achutti @@oth@@ Curigliano, Giuseppe @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV019637179 |
dewey-sort |
3610 |
id |
ELV045484325 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045484325</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624115101.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.critrevonc.2018.11.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000492.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045484325</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1040-8428(18)30422-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Morganti, Stefania</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor mutational burden</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Precision medicine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Driver mutations</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Predictive biomarkers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor heterogeneity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Liquid biopsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Next generation sequencing</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tarantino, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferraro, Emanuela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D’Amico, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viale, Giulia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trapani, Dario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duso, Bruno Achutti</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Curigliano, Giuseppe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Dettori, D. ELSEVIER</subfield><subfield code="t">miR-214 in stroma cells and tumor progression</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV019637179</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:133</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:171-182</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.critrevonc.2018.11.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2016</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">133</subfield><subfield code="j">2019</subfield><subfield code="h">171-182</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
author |
Morganti, Stefania |
spellingShingle |
Morganti, Stefania ddc 610 bkl 44.52 Elsevier Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
authorStr |
Morganti, Stefania |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV019637179 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.52 bkl Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing Elsevier |
topic |
ddc 610 bkl 44.52 Elsevier Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing |
topic_unstemmed |
ddc 610 bkl 44.52 Elsevier Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing |
topic_browse |
ddc 610 bkl 44.52 Elsevier Tumor mutational burden Elsevier Precision medicine Elsevier Driver mutations Elsevier Predictive biomarkers Elsevier Tumor heterogeneity Elsevier Liquid biopsy Elsevier Next generation sequencing |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
p t pt e f ef p d pd g v gv d t dt b a d ba bad g c gc |
hierarchy_parent_title |
miR-214 in stroma cells and tumor progression |
hierarchy_parent_id |
ELV019637179 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
miR-214 in stroma cells and tumor progression |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV019637179 |
title |
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
ctrlnum |
(DE-627)ELV045484325 (ELSEVIER)S1040-8428(18)30422-0 |
title_full |
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
author_sort |
Morganti, Stefania |
journal |
miR-214 in stroma cells and tumor progression |
journalStr |
miR-214 in stroma cells and tumor progression |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
171 |
author_browse |
Morganti, Stefania |
container_volume |
133 |
physical |
12 |
class |
610 VZ 44.52 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Morganti, Stefania |
doi_str_mv |
10.1016/j.critrevonc.2018.11.008 |
dewey-full |
610 |
title_sort |
complexity of genome sequencing and reporting: next generation sequencing (ngs) technologies and implementation of precision medicine in real life |
title_auth |
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
abstract |
Display Omitted |
abstractGer |
Display Omitted |
abstract_unstemmed |
Display Omitted |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 |
title_short |
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life |
url |
https://doi.org/10.1016/j.critrevonc.2018.11.008 |
remote_bool |
true |
author2 |
Tarantino, Paolo Ferraro, Emanuela D’Amico, Paolo Viale, Giulia Trapani, Dario Duso, Bruno Achutti Curigliano, Giuseppe |
author2Str |
Tarantino, Paolo Ferraro, Emanuela D’Amico, Paolo Viale, Giulia Trapani, Dario Duso, Bruno Achutti Curigliano, Giuseppe |
ppnlink |
ELV019637179 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth |
doi_str |
10.1016/j.critrevonc.2018.11.008 |
up_date |
2024-07-06T17:40:04.577Z |
_version_ |
1803852295257980928 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045484325</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624115101.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.critrevonc.2018.11.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000492.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045484325</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1040-8428(18)30422-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Morganti, Stefania</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor mutational burden</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Precision medicine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Driver mutations</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Predictive biomarkers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor heterogeneity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Liquid biopsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Next generation sequencing</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tarantino, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferraro, Emanuela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D’Amico, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viale, Giulia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trapani, Dario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duso, Bruno Achutti</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Curigliano, Giuseppe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Dettori, D. ELSEVIER</subfield><subfield code="t">miR-214 in stroma cells and tumor progression</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV019637179</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:133</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:171-182</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.critrevonc.2018.11.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2016</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">133</subfield><subfield code="j">2019</subfield><subfield code="h">171-182</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
score |
7.4001417 |